Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1983 1
1985 2
1986 1
1991 1
1992 1
1993 1
1994 1
1995 2
1996 3
1997 5
1998 3
1999 7
2000 7
2001 9
2002 11
2003 7
2004 25
2005 22
2006 28
2007 24
2008 32
2009 32
2010 59
2011 58
2012 76
2013 68
2014 111
2015 73
2016 90
2017 86
2018 88
2019 104
2020 90
2021 113
2022 116
2023 114
2024 119
2025 116
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,513 results

Results by year

Filters applied: . Clear all
Page 1
Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes.
Hyeon DY, Nam D, Han Y, Kim DK, Kim G, Kim D, Bae J, Back S, Mun DG, Madar IH, Lee H, Kim SJ, Kim H, Hyun S, Kim CR, Choi SA, Kim YR, Jeong J, Jeon S, Choo YW, Lee KB, Kwon W, Choi S, Goo T, Park T, Suh YA, Kim H, Ku JL, Kim MS, Paek E, Park D, Jung K, Baek SH, Jang JY, Hwang D, Lee SW. Hyeon DY, et al. Among authors: kim yr. Nat Cancer. 2023 Feb;4(2):290-307. doi: 10.1038/s43018-022-00479-7. Epub 2022 Dec 22. Nat Cancer. 2023. PMID: 36550235
NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma.
Kim S, Kwak JE, Koh JY, Lee JE, Kook HW, Kim M, Chung H, Kim YR, Kim SJ, Kim JS, Cheong JW, Lee MG, Lee H, Park SH, Shin EC, Shin S, Yoon SO, Choi IK, Lee JS, Cho H. Kim S, et al. Among authors: kim yr. Blood. 2025 Jul 24;146(4):456-470. doi: 10.1182/blood.2024025875. Blood. 2025. PMID: 40106762
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea.
Mok J, Lee M, Kim DK, Kim JS, Jhun BW, Jo KW, Jeon D, Lee T, Lee JY, Park JS, Lee SH, Kang YA, Lee JK, Kwak N, Ahn JH, Shim TS, Kim SY, Kim S, Kim K, Seok KH, Yoon S, Kim YR, Kim J, Yim D, Hahn S, Cho SN, Yim JJ; MDR-END investigators. Mok J, et al. Among authors: kim yr. Lancet. 2022 Oct 29;400(10362):1522-1530. doi: 10.1016/S0140-6736(22)01883-9. Lancet. 2022. PMID: 36522208 Clinical Trial.
Micrococcin P2 Targets Clostridioides difficile.
Son YJ, Kim YR, Oh SH, Jung S, Ciufolini MA, Hwang HJ, Kwak JH, Pai H. Son YJ, et al. Among authors: kim yr. J Nat Prod. 2022 Aug 26;85(8):1928-1935. doi: 10.1021/acs.jnatprod.2c00120. Epub 2022 Jul 11. J Nat Prod. 2022. PMID: 35816693 Review.
Update on the POEMS syndrome.
Kim YR. Kim YR. Blood Res. 2022 Apr 30;57(S1):27-31. doi: 10.5045/br.2022.2022001. Blood Res. 2022. PMID: 35483922 Free PMC article. Review.
1,513 results